Chicharros USA - bolsa internacional

Rprudem ten paciencia, aún es muy temprano, en pre las cosas suben y bajan como un tobogán....veremos algom mas claro ahí sobre las 15:00H

LJPC
Aquí noticia día 21 diciembre
Sube un 14% en el Pre.

FDA Approves La Jolla Pharmaceutical's (LJPC) Giapreza for Dangerously Low Blood Pressure
December 21, 2017 6:00 PM
The U.S. Food and Drug Administration today approved La Jolla Pharmaceutical's (NASDAQ: LJPC) Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.

"Shock, the inability to maintain blood flow to vital tissues, can result in organ failure and death," said Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and Renal Products in the FDA’s Center for Drug Evaluation and Research. "There is a need for treatment options for critically ill hypotensive patients who do not adequately respond to available therapies."

Blood pressure is the force of blood pushing against the walls of the arteries as the heart pumps out blood. Hypotension is abnormally low blood pressure. Shock is a critical condition in which blood pressure drops so low that the brain, kidneys and other vital organs can't receive enough blood flow to function properly.

In a clinical trial of 321 patients with shock and a critically low blood pressure, significantly more patients responded to treatment with Giapreza compared to those treated with placebo. Giapreza effectively increased blood pressure when added to conventional treatments used to raise blood pressure.

Giapreza can cause dangerous blood clots with serious consequences (clots in arteries and veins, including deep venous thrombosis); prophylactic treatment for blood clots should be used.

This application received a Priority Review, under which the FDA’s goal is to take action on an application within six months when the agency determines that the drug, if approved, would significantly improve the safety or effectiveness of treating, diagnosing or preventing a serious condition.

The FDA granted the approval of Giapreza to La Jolla Pharmaceutical Company.

The FDA, an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco

Bitcoin a 13700$ habiendo estado cerca de 12000
A ver qué nos hacen hoy las cryptos

RXDX
Esta si que es buena... RXDX es Ignyta
En premarket 72% ahora

Roche to buy U.S. cancer drugmaker Ignyta for $1.7 bln
Reuters
ReutersDecember 22, 2017
Logo of Swiss drugmaker Roche is seen beside the entrance of its research unit Roche Glycart AG in Schlieren, Switzerland December 18, 2017. REUTERS/Arnd Wiegmann
Logo of Swiss drugmaker Roche is seen beside the entrance of its research unit Roche Glycart AG in Schlieren
Logo of Swiss drugmaker Roche is seen beside the entrance of its research unit Roche Glycart AG in Schlieren, Switzerland December 18, 2017. REUTERS/Arnd Wiegmann
More
(Reuters) - Swiss drugmaker Roche will buy U.S. cancer drug specialist Ignyta Inc for $1.7 billion in an agreed deal to broaden its oncology portfolio, the firms said on Friday.

Roche would pay $27 per share for Ignyta, representing a premium of about 74 percent to the stock's closing price on Thursday, they said.

Reuters had reported on Thursday that Ignyta was in advanced talks to sell itself, just three years after going public with a focus on precision drugs and diagnostics.

RXDX
El acuerdo es a 27$

Bitcoin.

Supongo que sabéis que desde principios de este mes ya existe el contrato de futuro en el CBOE, Chicago.

Ahora las riendas las toman ya los profesionales y las maquinitas, claro.

https://www.cointelegraph.es/explained/bitcoin-futures-explained

Bit Bit

Sí, hará cosa de tres semanas, ví un vídeo del trader Marcelo que decía que ya habían bit-futuros en el mercado de Chicago. A este tio lo que más le gustan son los futuros.

BT a todos

Ya no hay nada que rascar...sale la noticia en pre y ya alcanza el precio maximo...